Adverse Drug Reactions and Drug Safety

Monitoring adverse drug reactions (ADRs) is essential for ensuring drug safety. ADRs, ranging from mild effects to severe toxicity, can result from drug interactions, genetic factors, or dosage errors. Pharmacovigilance systems have evolved to track ADRs post-marketing, enabling early detection of risks. Personalized medicine, through pharmacogenomics, improves drug safety by predicting individual responses to therapies, minimizing ADRs, and optimizing treatment. Regulatory frameworks also play a crucial role in maintaining drug safety.

    Related Conference of Adverse Drug Reactions and Drug Safety

    February 19-20, 2026

    6th World Congress on Climate Change and Ecosystem

    Paris, France
    May 14-15, 2026

    14th World Conference on Climate Change

    London, UK
    June 22-23, 2026

    8th Global Summit on Environmental Health

    London, UK
    June 29-30, 2026

    13th International Conference on Recycling & Waste Management

    Aix-en-Provence, France
    July 09-10, 2026

    21st World Bioenergy Congress and Expo

    Zurich, Switzerland
    July 27-28, 2026

    18th World Congress and Expo on Recycling

    Rome, Italy
    July 30-31, 2026

    11th Global Summit on Climate Change

    Paris, France
    August 10-11, 2026

    14th World Congress and Expo on Green Energy

    Berlin, Germany
    September 14-15, 2026

    20th Global Summit and Expo on Biomass and Bioenergy

    Rome, Italy
    September 14-15, 2026

    20th World Congress on Biofuels and Bioenergy

    Rome, Italy
    October 29-30, 2026

    14th International Conference on Green Energy

    Paris, France
    November 19-20, 2026

    15th World Conference on Earth Science & Geology

    Dubai, UAE

    Adverse Drug Reactions and Drug Safety Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in